Search
Bronchopulmonary Dysplasia Clinical Trials
A listing of 17 Bronchopulmonary Dysplasia clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
13 - 17 of 17
There are currently 17 active clinical trials seeking participants for Bronchopulmonary Dysplasia research studies. The states with the highest number of trials for Autism participants are Ohio, California, Florida and Texas.
Featured Trial
Major Depressive Disorder Clinical Study
Recruiting
Is depression weighing you down? Local major depressive disorder clinical studies are now enrolling participants in the area. Participating in research studies helps contribute to the advancement of future medicine and treatment options. There is no obligation to take part and health insurance is not required.
Conditions:
Major Depressive Disorder
Major Depression
Major Depressive Episode
Major Depressive Disorder (MDD)
Major Depressive Disorders
Featured Trial
Hyperacusis Activities Treatment-Online Study
Recruiting
Are you experiencing hyperacusis? If so, we are recruiting adults with hyperacusis to complete a clinical trial supported by the National Institutes of Health. The study involves participating in a remote counseling program and sound therapy trial for hyperacusis, Hyperacusis Activities Treatment-Online.
Conditions:
Hyperacusis
Tinnitus
Hearing Loss
NAVA vs. CMV Crossover in Severe BPD
Recruiting
This prospective, unblinded, pilot randomized cross-over trial of 2 modes of mechanical ventilation will compare measures of pulmonary mechanics, respiratory gas exchange, and patient comfort between conventional flow triggered mechanical ventilation and neurally adjusted ventilatory assist (NAVA) among 20 prematurely born infants and young children receiving invasive respiratory support for severe bronchopulmonary dysplasia (BPD).
Gender:
All
Ages:
24 months and below
Trial Updated:
08/08/2023
Locations: Children's Hospital of Philadelphia, Philadelphia, Pennsylvania +1 locations
Conditions: Bronchopulmonary Dysplasia, Neurally Adjusted Ventilatory Assist, Mechanical Ventilation
Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia
Recruiting
Inhaled nitric oxide (iNO) is an effective treatment for pulmonary hypertension (PH) in term and near-term infants. Preterm infants are at risk for early PH that is associated with high risk for bronchopulmonary dysplasia or death. In multiple clinical trials, iNO treatment was not effective for BPD prevention. However, infants were not screened for PH and iNO treatment was not targeted for PH. iNO treatment for PH in preterm infants is controversial due to lack of evidence. The study team hypot... Read More
Gender:
All
Ages:
Between 23 weeks and 29 weeks
Trial Updated:
06/28/2023
Locations: AdventHealth, Orlando, Florida
Conditions: Pulmonary Hypertension, Bronchopulmonary Dysplasia
Impact of Extended CPAP on Bronchopulmonary Dysplasia
Recruiting
The purpose of this pilot study is to compare if keeping infants on CPAP (continuous positive airway pressure) support for an extended period of time until they are 32 weeks corrected gestational age or 1250 grams (approximately 2 pounds and 12 ounces) will decrease their degree of lung disease as compared to weaning their respiratory support to HFNC (high flow nasal cannula).
Gender:
All
Ages:
Between 22 weeks and 30 weeks
Trial Updated:
10/17/2022
Locations: Christiana Care Health Services, Inc., Newark, Delaware
Conditions: Bronchopulmonary Dysplasia, Prematurity
Indoor Air Quality and Respiratory Morbidity in School-Aged Children With BPD
Recruiting
Investigators want to learn the role of indoor environmental exposures on respiratory symptoms, and, separately, on lung function deficits in school-aged children with bronchopulmonary dysplasia (BPD).
Gender:
All
Ages:
Between 6 years and 12 years
Trial Updated:
09/20/2022
Locations: Boston Childrens Hospital, Boston, Massachusetts
Conditions: Bronchopulmonary Dysplasia, Chronic Lung Disease of Newborn, Environmental Exposure
Glucocorticoids and Pulmonary Hypertension
Recruiting
Pediatric idiopathic pulmonary hypertension has significant morbidity and mortality. An ever expanding body of knowledge indicates the important contribution of inflammation to pathogenesis and successful treatment with glucocorticoids. Over the last several years the investigators have utilized steroids in patients with severe pulmonary hypertension as part of a treatment regimen. These basic science studies possibly identifies a biochemical etiology for the development of disease and may also... Read More
Gender:
All
Ages:
Between 1 day and 5 years
Trial Updated:
03/17/2022
Locations: St. Louis Children's Hospital, Saint Louis, Missouri
Conditions: Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Pulmonary Hypertension, Bronchopulmonary Dysplasia
13 - 17 of 17